Pharmacogenetic Study in Patients Received Iron Chelating Agent

Hemosiderosis

Non-invasive Quantification of Liver Iron With MRI Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients Pharmacogenetic Study in Patients Received Iron Chelating Agent Efficacy Study in Removing Excess Iron From the Heart Safety, Tolerability, and Efficacy of Deferasirox in MDS A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)